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INTRODUCTION.
Since the year 1911 several observers, notably
in Sweden, Holland, Germany and more especially
America, have published numerous articles on the
action of quinine in'pneumonia. It is remarkable that
a form of treatment for which large claims are made
elsewhere has received so little attention in this
country: Gibson in praise of the treatment of pneumonia
with quinine and Sir Almroth Wright, who condemns the
use of ethylhydrocuprein hydrochloride - optochin or
Morgenroth's drug - in pneumonia, are noteworthy
exceptions.
Professor W. E. Dixon referred to the treatment
of pneumonia with ethylhydrocuprein hydrochloride, in a
discussion, at the annual meeting, of the British B/Tedical
Association at Cambridge in 1920. He said that it was
difficult to explain why physicians had not obtained
more striking results with a drug, which, administered
in therapeutic doses, destroys the primary cause of the
disease.
In view of the many interesting observations in
the literature and favourable statements by clinicians,
who have used preparations of quinine other than ethyl¬
hydrocuprein hydrochloride, it would appear desirable to
carry out a series of observations upon the action of
quinine urea - quinine and urea hydrochloride - in lobar
and lobular pneumonia. The object of this paper is to
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illustrate with a series of cases the value of quinine
as a therapeutic agent in pneumonia and to discuss, in
the light of facts already ascertained, the prospect of
further research into its mode of action.
REVIEW OF LITERATURE.
In the yeai" 1875 Schultz (1), of Mount Vernon,
Indiana, had under observation tv.ro hundred and thirty-
eight cases of lobar pneumonia. The cases presented the
toxic symptoms associated with a virulent infection.
Schultz treated all his patients with quinine and was
impressed with the favourable results: he said 'How
quinia accomplishes good results .... has not yet been
determined. I opine that it is not by its fever-lower¬
ing property, for I have seen the general condition ....
improved even when no impression was made on the tempera¬
ture. .. There seems to be inherent in quinia, when
given in large doses, a specific power of so influencing
diseases attended with great and rapid tissue metamor -
phosis and retention of the waste-products of such
tissue changes in the system that the diseases take on a
more favourable course and come to a more happv' issue
under its use.'
It was not, however, until the year 1904 that a
systematic attempt was made to treat pneumonia with
quinine. In that year G-albra-ith (2) revived the treat¬
ment of pneumonia by quinine in massive doses, and it
was this that led Solis Cohen to employ it at the
Philadelphia General Hospital. For his experiments he
used quinine urea which he administered by hypodermic
injection. The initial dose was fifteen to twenty-five
grains followed in three to four hours by a second
injection and perhaps by a third and even a fourth
injection some time within the first twenty four hours
according to results. Occasionally it was thought de¬
sirable to continue with large doses on the second and
third day, followed by smaller doses by the mouth. Some
cases must have re'ceived more than four drachms of quinine
urea in three days yet" quinine poisoning did not occur.
In the year 1911 Solis Cohen (3) published the
results of his observations made upon a large number of
cases and extending over a period of several years. He
found that the temperature and pulse rate fell gradually
and proportionately. The respiration rate fell more
rapidly, with a tendency to restitution of the normal
pulse-respiration ratio. The blood pressure, which
sometimes fell after the injection, soon returned to the
former or a higher level. The structural pathological
processes evolved in the customary manner apparently un¬
modified by the treatment. The termination was by lysis
at about the ordinary time: crisis did not occur. The
complete clinical picture was thus favourably changed.
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He says 'The most striking results of the large doses of
quinine urea are thus functional; and since the most signi¬
ficant features are relief of respiration and the mainten¬
ance of normal cardiac vigor and blood pressure, it seems
logical to infer that the effect is chemical and anti¬
toxic. This view is further borne out by the absence of
quinine intoxication, suggesting a mutual neutralization
of disease-poison and drug.1 He considered that the urea
radicle might be a chemical sensitizer, or linking body;
or that it might delay the excretion of the quinine.
In Hay of the same year - 1911 - Gibson (4) , ad-
ressing the Eastern Medical Society of G-lasgow on lobar
pneumonia said 'In cases where there is severe toxaemia
and great leucocytisis much may be done by the employment
of quinine. In several instances of this kind - in which
the patients had even reached a stage of profound coma,
with complete relaxation of the sphincters and every evi¬
dence of imminent danger - the hypodermic use of quinine
has produced the most remarkable effects. The best prepa¬
ration for this purpose is the acid hydrochloride, which
is extremely soluble and which may be administered hypoder-
mically in doses of two grains every two hours, or every
hour. Ho more gratifying results have ever occurred in my
own hands than from this method of treatment."
It was not until six years later that further
reference was made to the action of quinine-urea in pneu¬
monia; during these intervening years, however, much inter¬
esting work was reported on the action of ethylhydrocuprein
hydrochloride in relation to pneumonia.
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Morganroth and Levy (5) experimented with ethyl-
hydro cuprein hydrochloride on mice inoculated with cultures
of pneumococcus. They found that the drug possessed
marked prophylactic and therapeutic value; when adminis¬
tered before inoculation it prevented the development of
infection in nearly every case, while when it was adminis¬
tered after inoculation half the cases were cured. Every
untreated mouse died.
'Sir Almroth Wright (6) investigated Murgenroth's
discovery with a view to ascertaining whether ethyl-
hydrocuprein hydrochloride might have any therapeutic value
in the pneumonias, of man. He established the fact that
this drug has a specific bactericidal effect on the pneumo¬
coccus in vitro and in vivo. Bactericidal experiments were
conducted in vitro on the blood fluids and urine of un¬
treated mice and mice receiving the same dose of ethyl-
hydro cuprein hydrochloride as Morganroth employed in his
experiments. The serum and urine of those that received
the drug were found to be strongly penumococcicidal, and
this power was not diminished by heating to 60° C. Further
experiments, carried out in part on normal men and in
part on pneumonia patients, showed that the blood of man is
also rendered bactericidal to the pneumococcus by the ad¬
ministration of ethylhydrocuprein hydrochloride. The
opsonic power of the serum is not appreciably affected. It
was sound found, however, that the drug did not conform to
the idealof being poisonous for the pneunococcus and non-
poisonous for the more special tissues of the patient. Of
Of twenty-one pneumonia patients, treated by Frankel,
three developed amblyopia, and in a further series of
eight cases, treated by Sir Almroth Wright, there were
two cases of amblyopia, one of which went on to amaurosis.
The dose was 0.5 to 2 gm, daily. The treatment was
therefore abandoned, and as there was insufficient
material on which to base trustworthy comparative sta¬
tistics it was decided not to draw conclusions from any
one feature, such as the case-mortality, but to give
attention to any significant clinical manifestation.
There were no clinical manifestations in the cases under
observation, and Sir Almroth Wright concluded that ethyl-
hydrocuprein hydrochloride does not exert a favourable
influence on human pneumonia. In connection with the
inefficacy or practical inefficacy of the drug as a reme¬
dial agent in human pneumonia Sir Almroth Wright sug¬
gests two possible explanations.
(1) That the advantage, which one might expect to
reap fronrthe circumstance that a bactericidal power is
conferred upon the blood fluids by ethylhydrocuprein
hydrochloride, is neutralized by some other antibacter¬
ial property diminishing. Thus, although the opsonic
power of the blood .is apparently unaltered, he consider¬
ed it possible that, as a result of some devitalising
action of the drug on the phagocytes, the ingested
microbes might not be destroyed.
(2) That in mice the pneumonic infection takes the
form of a septicaemia and as a result the drug has free
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access to the infecting organisms; whereas the tissue
spaces in association with a consolidated lung are
filled up with coagulated lymph and thus the influx of
bacteriotropic substances from the blood is prevented.
It would seem desirable, at this point, to com¬
plete the references to ethylhydrocuprein hydrochloride,
postponing for the time reference to quinine urea, al¬
though this will involve departure from precise
chronological order.
In the year 1916 Moore and Chesney (7) reported
the results of a series of experiments on the action of
ethylhydrocuprein hydrochloride on the pneumococcus.
These experiments confirmed the earlier work of Morgen-
roth and Sir Alrnroth Wright: its bactericidal action
extends to the four main groups of pneumococcus and the
serum of animals and man receiving the drug acquires an
inhibitory and bactericidal power. The rabbit, however,
presents an interesting exception to this rule.
Weiss (8) demonstrated that the administration of
various quinine derivatives - including ethylhydrocuprein
hydrochloride - to the rabbit does not produce a pneuno-
coccicidal action in its serum, but Solis Cohen (9)
was able to protect rabbits with a dose of 0.01 gm. of
ethylhydrocuprein hydrochloride per kiligram of body
weight against fifty minimal lethal doses of pneumococcus
given two hours later by intravenous injection - a
dose, weight for weight, very much larger than is re¬
quired to afford protection in mice.
The fact that the liver of the rabbit has a high
destructive action on quinine alkaloids and that both
leucocytes and red blood cells have a marked affinity
for cinchona compounds is a possible explanation of why
it is impossible to render the serum of the rabbit
pneumococcicidal by administration of quinine deriva¬
tives.
A bectericidal action for the pneurnococcus is
secured in the blood stream of patients if they are
given an amount of ethylhydrocuprein hydrochloride
represented by . 0S4- gm. per kilogram of body weight per
twenty-four hours. (Chesney, (10).) The time of
appearance of the bactericidal action in the serum is
shortened and the possibility of invading bacteria
becoming fast to the drug is less when the first dose
is relatively large.
Prom October 1915 to May 1917 Moore and
Chesney (11) gave an extended trial to this drug.
Almost all the cases of lobar pneumonia admitted to the
wards of the Hospital of the Rockefeller Institute
during this period were treated with ethylhydrocuprein
hydrochloride - cases due to pneumococcus type I did not
receive the drug, but were treated with specific
immune serum. The results v/ere disappointing. In four
per cent of the cases treated temporary impairment of
vision had occurred and in one case permanent blindness.
They attribute the failure to the fact that the toxicity
of ethylhydrocuprein hydrochloride was such as to keep
the limit of dosage below the limit of effectiveness:
a concentration of about one in five-hundred thousand,
which is as much as may safely be attained in, the blood
stream of the patient, is not sufficient to penetrate
the alveolar exudate to any marked degree. The peri¬
cardial fluid, obtained post mortem, showed pneumococci-
cidal power, and the serum of one patient who received
a very large dose was also pneumococcicidal.
Kolraer (12) was able to demonstrate that ethyl-
hydro cuprein hydrochloride by subcutaneous injection in
doses without protective value, usually increases the
protective value of antipneumococcus serum type I in a
slight but definite manner in sever infections of mice
and rats with homologous pneumococci.
Soils Cohen (13) has confirmed these observa¬
tions in connection with a more general consideration of
most of the quinine derivatives in relation to pneumonia.
Amongst the quinine derivatives tested were quinine urea
ethylhydrocuprein hydrochloride, quinine bisulphate and
quinine hydrooromide. .All were found to exert a high
bactericidal power on pneumococcus in vitro, and that
this action was a specific one was shown by cross bacteri
cidal tests - employing on the one hand quinine deriva¬
tive with cultures of B. typhosus and of a staphylococcus
and on the other hand arsenobenzol, phenol, mercuric
chloride, and sodium salicylate with cultures of
pneumo c o c cus.
Thus the value of ethylhydrocuprein hydrochlorid
the most active as a bactericide, was from two-hundred
to four-hundred times greater for the pneumococcus than
for B: typhosus and the staphylococcus. The various
quinine derivatives however differed markedly in their
relative pneumococcicidal power and quinine urea was
found'_to be one of the weakest in this respect (Cohen
(14-).) Their protective power against virulent infections
of pneumocoecus in mice and rabbits also varied and
again quinine urea was the least potent. The protec¬
tion is greater when the drug is given intravenously
than intramuscularly, and in the case of quinine urea it
is most narked when repeated injections are given, when
it has a marked curative value. Solis Cohen lays stress
on the prolongation of life in infected mice receiving
repeated injections of non-toxic doses of quinine urea-
or ethylhydrocuprein hydrochloride -, and says 'For
such prolongation in man gives time for the development
of the natural immunity which is manifested by
critical recovery in untreated cases and by gradual
defervescence in cases treated with quinine.'
An investigation into the action of these
various quinine derivatives on phagocytosis revealed
the fact that, in high dilution, they accelerate the
phagocytosis of pneumococci by rabbit leucocytes
while low dilutions retard phagocytosis and induce
degenerative changes in the leucocytes. It was also
found that, injected intra-muscularly into rabbits, they
increase the phagocytic power of the rabbit sera for
pneumococci, ... These results are in accord with clinic¬
al observations. Soils Cohen says, - 'Contrary to
expectation-, the administration of quinine in any
form and by any method to a patient in the early
stages of a lobar or lobular pneumonia not only does
not- reduce Hie numbers or the apparent activity of the
leucocytes, but - so far as one may judge in an .
infection normally accompanied with a progressive
increase in the white-cell count - actually seems
to increase them. '
In clinical studies of the beneficial
influence of quinine salts in the pneumonias of man
Solis Cohen (15) observed three outstanding facts:
JL. The relief of toxic symptoms without appreciable
influence on the evolution of physical signs, 2, the
change of termination from crisis to lysis and J3, the
absence of quinine poisoning, even when enormous doses
are given - this does not apply to ethylhydrocuprein
hydrochloride however. He says, 'There is nothing
in the known pharmacologic influence of quinine as a
function modifier that will account for either the first
or the second of these facts. Nor can bactericidal
action alone explain them. The third fact indicates
the presence of a quinine-tolerance in the subjects of
pneumonia.' It appeared that there might be a mutual
antagonization or inhibition, physical or chemical,
direct or indirect, of quinine by the pneumonia poison-
complex, and of the pneumonia poison-complex by quinine.
The following experiments were undertaken by Solis
Cohen, Weiss and Kolmer in the hope that they might
throw light on the problem. While admitting that the
finding of the poison or poisons in question should
logically precede such investigation it was deemed
practicable to pursue the two lines of research
together, partly in the hope that one might throw
light on the other; and partly that at least certain
preliminary questions as to the possible action of
quinine might be determined. They experienced great
difficulty in demonstrating an endocellular toxin in
the pneumococcus , and were unable to produce uniformly
a toxin which was hemolytic and also produced anaphylaxis
on primary intravenous injection in guinea-pigs. The
•organism used was Type I prxeumococcus , and it was trans¬
planted every other day and from time to time passed
through a mouse in order to maintain the M.L.D. for
mice (24 hours) at 0.000,000,1 c.c. of a twenty four
hour broth culture. Elaborate precautions were taken
in the preparation of the pneumotoxin and its toxicity
was tested by intravenous injections in guinea-pigs .and
white mice, and by intra-peritoneal injection in white
mice. Having established the lethal dose of each
preparation of pneumotoxin, attempts were made to neutral¬
ize its toxicity by means of the various quinine
derivatives.
In the.first experiment the toxin and drug were
mixed in the test tube in proper proportions and, after
a period of incubation at room temperature, injected
intravenously into a guinea-pig. This method was aban¬
doned however as it was found that the quinine was
precipitated. In the second experiment the proper
dose of the drug was injected into the animal two
hours before the injection of 2 M.L.D, of the toxin:
the animals all died. An attempt was then made to study
the effect of repeated injections of sublethal doses
of pneumotoxin followed by a corresponding dose of
quinine salt. This experiment, representing more closely
the conditions which obtain when the drug is exhibited
to a pneumonia patient, had to be abandoned because of
the extreme lability and rapid deterioration of the
pneumotoxih. A fourth experiment showed that quinine
salts exert no inhibition on the hemolytic activity of
pneumotoxin. In fact the reverse phenomenon was obser¬
ved: there was a summation of hemolytic powers.
Prom human lung tissue in the stage of grey
hepatization, obtained post mortem, Solis Cohen was
able to prepare a highly toxic extract producing
anaphylactic-like symptoms in guinea-pigs and rabbits.
Attempts to neutralize this lung toxin with quinine
derivatives gave inconstant results. Thus it was found
that while quinine hydrochloride, quinine urea and
ethylhydrocuprein hydrochloride gave little or no
protection, quinine hydrobromide exerted a marked
neutralizing action on the toxicity of the pneumonic
lung extract, prolonging the life of the animal up to
five days or more after the injection of 1 M.L.D.
The pneumonic lung extract was found to be
strongly hemolytic, and attempts to neutralize its
hemolytic power with quinine derivatives gave some¬
what paradoxical results;- thus ethylhydrocuprein
hydrochloride, quinine and quinine urea gave a slight
inhibition when large doses were used, while quinine
hydrochloride, quinine hydrobromide and quinine bi-
sulphate behaved in a reverse way, giving marked
inhibition in nonlytic doses and no inhibition in lytic
doses.
Attacking the problem from another angle
attempts were made to ascertain whether or not the
pneumococcus protein or substances present in the blood
of pneumonia patients would exert a neutralizing
influence in quinine poisoning. The experiments were
barren of result.
A detailed record of these experiments , .briefly
referred to above, concludes, - 'Neither the clinically
beneficial action of cinchona derivatives in the
pneumonias nor the increased tolerance of pneumonia
patients receives elucidation from the experiments Re¬
ported; the results being largely negative. Certain
suggestive phenomena were observed that further study
may elucidate. That cinchona derivatives are specific¬
ally pneuraococcicidal and that they increase phagocytic
activity has been shown in previous papers. Whether
their influence on general metabolism and in general
antibody production will suffice to explain their
further protective and curative influence remains to
be determined.'
Solis Cohen (16) considers quinine the pharma¬
codynamic centre in the treatment of pneumonia, and
postpituitary and digitalis as the principal pharma¬
codynamic aids. He says, 'I have found no other agents
equal to them, except, within limitations, the specific
type I serum in type I cases and mixed (polyvalent)
pneumonia bacterins in other cases.' Nice (17) also
reports favourably on the action of quinine in pneumonia.
Solis Cohen does not employ quinine for the purpose of
reducing temperature, but to combat bacteria, bacterial
poisons and tissue poisons. The reduction of temperature
is an incident of its action and affords a guide for
dosage, both as to quantity and frequency. Commonly,
he says, the temperature, if aoove 102 f. is brougt to
or below that figure within three or four hours after the
administration of the drug in sufficient quantity, while
a persistent tendency to reascend is the indication for
continuing or increasing the medication. As a rule
cases which did not respond were found,, post mortem, to
have extensive plural or pulmonary suppuration. Solis
Cohen considers quinine hydrobromide the preferable salt
of quinine for administration by mouth, and for intra¬
muscular injection either of these or the dihydrochloride.
He advocates massive dosage and says 'I have not myself
encountered any instance of untoward cinchonism .. in
this respect the unmodified quinine molecule differs
very much from trhe ethylhydrocuprein hydrochloride,
whose toxicity is so great as to render it unsafe for
internal use. Even'in cases of quinine idiosyncrasy
it will be found that quinine in large doses is well
tolerated during the progress of an acute lobar pneu¬
monia. ' He recommends as an initial dose by the mouth
twenty-five to thirty-five grains, and intramuscularly
twenty to twenty-five grains, followed in either case
by smaller doses at three to four hour intervals. For
intravenous injection ten to fifteen grains in 100 c.c.
of physiologic sodium chloride solution is advised: one
dose by the intravenous route will usually be found
sufficient.
A review of the literature on this subject
would not be complete without reference to Professor
¥.• E. Dixon's (18) observations on quinine and its
related alkaloids in pharmacology and therapeutics.
He says, - 'Quinine is peculiar among alkaloids in that
it has no very definite specific action on any particu¬
lar tissue in the body. Its action on all living
tissues is to cause diminished activi ty and diminished
metabolic changes. Sometimes there is a transcient
increase of activity before the depression is evident ..
The spirochaetes of vegetable decomposition become
motionless in the presence of quinine in strength of
one in ten-thousand similar concentrations of
quinine in the blood act on the white blood cells in
the same way .... movements cease and the corpuscle
becomes granular. Quinine, then, should have the
power to limit inflammatory processes, for it prevents
the migration of white blood cells, and it is possible
that the internal administration of large doses of
quinine may limit pus formation.' He observed that the
action of quinine is not confined to intact• protoplasm
but extends to the ferments, some of which act better
in very dilute solutions; while traces of quinine in
the blood inhibits acid formation. Referring to the
specific pneumococcicidal power of ethylhydrocuprein
hydrochloride he says - 'It is not easy to explain
why physicians have not obtained more striking re¬
sults with a drug which destroys the primary cause of
the disease. It is of comparatively little value
to administer tetanus antitoxin when the toxin has
already poisoned the nerve cells, and I venture to
suggest that for a similar reason ethylhydrocuprein
hydrochloride may be of little value when the pneumonic
condition is at its height. The pathology of early
pneumonia is not well known, but the pneumococcus is
apparently plentiful only in the early stages of the
attack. The inflammatory process then continues in
the ordinary course and may go on, even though all
the pneumococci be dead. If this interpretation is
correct ethylhydrocuprein hydrochloride would be of
little value in the treatment of well pronounced
cases of pneumonia, but should be of inestimable value
in early cases and as a prophylactic. So certain are
we of our facts concerning this drug - that we can
render the blood of our patients pneumococcicidal -
that the gravest reasons only should condemn it to ob¬
livion. "
DESCRIPTION OP CASES.
At the Royal Naval Hospital, Chatham, during
the autumn of 1017, I had an opportunity of treating
several cases of lobar pneumonia with quinine urea.
Professor Gulland mentioned the treatment of pneumonia,
advocated by Solis Cohen, in his lectures on medicine
at the University of Edinburgh in 1916-17; and with
Professor G-ulland's observations as a guide I experi¬
mented on those cases of pneumonia which came under my
care. At first I administered quinine urea by hypo¬
dermic injection in concentrated solution, but soon
abandoned this practice as I found it was not in¬
frequently followed by necrosis at the site of injec¬
tion. The areas of necrosis varied from the size of a
pea to an inch or more in diameter, but in no case did
Nthe skin give way over one of these necrotic areas; and
apart from the grey discolouration of the skin over
the subadjacent necrotic tissue - in one case it was
still evident two months after the injection - I ob¬
served no ill effects. Latterly I have been able to
arrange with Messrs. Parke, Davis & Co,, for a supply
of five c.c, ampules each ampule containing a solution
of quinine urea in the strength of one grain in one
c.c. This is a convenient dilution for intramuscular
injection and no ill effects have followed its use.
No records are avilable of the cases of pneumo¬
nia which I treated with quinine urea in the Royal
Naval Hospital, Chatham. These cases were in the
nature of a preliminary investigation; but the results
were sufficiently encouraging to persuade me to continue
this form of treatment. The cases which I describe
occurred, during the last two years, in the course of
general practice in the New Forest.
CASE I.
■7.B. , a woman, aged 29; good personal and
family history, and of an exceptionally robust type,
complained of severe frontal headache and giddiness.
When I saw her she had a temperature of 101.5°, pulse
110 and respirations 23, she had had a rigor two hours
previously. • There was no cough and I detected no
modification of the breath sounds. Ten grains of
Dovers powder failed to give her a good night's rest,
she commenced a short dry cough, and had a second severe
rigor in the early morning. When I saw her, about
5 a.m., she was more comfortable but during the day she
 
got steadily worse and towards evening became delirious.
There was now considerable dyspnoea, the cough was
persistent and there were signs of a commencing patchy
consolidation of the right lung. A drachm and a half of
paraldehyde in brandy per rectum was followed by a short
period of restless sleep, and the patient commenced the
third day of the illness in an exhausted condition. At
noon the temperature was 102, vomiting commenced and it
became necessary to administer stimulants per rectum,
at 12 p.m. the patient collapsed - the temperature fell
to 98.6° and then to 97.6°, there was incontinence of
urine and faeces. For twelve hours the patient lay in
a semi-comatose condition, when the temperature rose
rapidly to 104°, the pulse was weak and irregular, the
breathing dyspnoeic and the whole clinical picture
that of profound toxaemia. I had now obtained a
supply of quinine urea and at once administered fifteen
grains intramuscularly. Within half an hour the tem¬
perature fell to 102°, the patient perspired freely and
was soon asleep. The following day - the fifth of' the
disease - the patient relapsed, toxic symptoms re¬
asserted themselves, and she appeared in imminent danger.
Dr. J. J. Perkins was called in consultation with Dr.
Gurney Dixon and myself; there was evidence of spread
of the disease to the left lung and the prognosis was
grave. The temperature was now 104.4°; fortunately a
second injection of fifteen grains of quinine urea was
followed by marked relief of the toxic symptoms, the
 
patient slept' and the temperature" fell to 99,6° without
any symptoms of collapse. On the sixth day of the
disease the temperature commenced to reascend, "but the
patient's general condition was more satisfactory, and
the vomiting having ceased rectal feeding was discon¬
tinued.
At 8 p.m., the temperature had risen to 103.8°
and I administered a third injection of ten grains of
quinine urea. As in both previous occasions the in¬
jection was followed by relief of toxic symptoms; the
patient progressed satisfactorily and further injections
were not called for. There was some deafness and
singing in the ears after the third injection; and con¬
valescence was unduly prolonged owing to the develop¬
ment of phlebitis in the right leg.
CASE 2.
A.M., a woman, aged SI, good personal and
family history and a robust type; complained of pain in
her stomach and headache. On examination her tempera¬
ture was 103O, pulse 130 and respirations 30. There
was evidence of commencing consolidation of the right
lower lobe. She v/as admitted to hospital on the second
day of the illness; her temperature on admission was
104.4°, but her general condition was satisfactory and
I decided to withhold the quinine urea. She experienced
a restless night, however, and as her condition in the
morning was less satisfactory I administered intra¬
muscularly ten grains of quinine urea. Two hours later
 
her temperature had fallen- to 102° and she slept for two
hours. The temperature continued to fall until at 8
p.m. it was 99.2°. She had a comfortable night. The
following day the sputum became rust coloured; the
temperature continued below 100-5O and the termination
was by lysis on the 5th day.
CASE 5.
M.B., a girl, aged 7, with a delicat© consti¬
tution and showing some evidence of rickets, developed
signs of a commencing consolidation of the right base'
while convalescing from chicken-pox. I administered
four grains of quinine urea intramuscularly. The
temperature dropped from 103.8° to 103° within half an
hour of the injection and continued to fall; six
hours later it was 97-8° and the child was sleeping
quietly. Apart from the fact that hex" respiration and
pulse rate continued high her appearance' suggested
that the disease had aborted. The following afternoon
the temperature rose to 102.20, and there were definite
signs of consolidation onvolving the right base , but
as her condition was satisfactory I did not l-epeat the
dose of quinine urea. The temperature continued
below 101.5° and the termination was by lysis' on the
fourth day.
CASE 4.
T.G-. , a boy, aged 18. This patient was an
ill-nourished gipsy, bi"ought in to hospital from his
 
tent in the New Forest, where he had been seen the
previous day by the district nurse. The nurse reported
that he complained of a pain in his chest, that his
temperature was 103° and that he had a bad cough. It
was difficult to obtain any history but it appeared
that he had been ill for three days. On admission his
face was cyanosed, his expression distressed, the
tongue was dry and brown and there was extreme
muscular prostration. He was got to bed and stimulants
were administered, the temperature rising rapidly from
990 - on admission - to 104°, lethargy gave way to
extreme restlessness and he became delirious. The pulse
was irregular and easily, compressible, the right heart
was dilated and the abdomen distended and tympanetic.
There were extensive patches.of consolidation in both
lungs. I administered l.c.c. of posterior pituitary
followed ten minutes later by fifteen grains of quinine
urea. The patient responded to the injections, became
less restless and the temperature fell gradually to
101.8°. At the same time his colour improved, he began
to pei"spire and the pulse became stronger and more
regular. He was no longer delirious but complained that
he was very tired and wanted to sleep. Two drachms
of paraldehyde with brandy per rectum were administered
and he obtained several hours sleep during the night.
The following day, however, he again became very
restless, his colour and the character of his pulse
were ominous, and I decided to give a further dose of
 
quinine urea. The injection was followed with the fall
in temperature and relief of toxic symptoms associated
with the administration of quinine in these cases and
the patient made an uninterrupted recovery.
CASE 5.
B.C., a woman, aged 73, with a history of
'winter-cough' of several years duration. She had
aortic incompetence and mitral incompetence and there
was- considerable hypertrophy of the left ventricle.
Organisms isolated from her sputum showed a preponder¬
ance of pneumococci, there was also micrococcus catarr¬
hal is and a few staphylococci but no tubercle bacilli.
She had had two series of inoculations of autogenous
vaccine, at four months interval, followed on both
occasions by a satisfactory period of relief from
bronchial catarrh: and I contemplated a third series
of inoculations when she developed an acute attack of
bronchitis. Her temperature during the first week of'
the illness ranged along the 100° line, with early
morning remissions of one degree or more. Her
respirations were not unduly distressed, but the cough
was troublesome and there was a small quantity of frothy
sputum. She took nourishment well, but the condition
of her heart gave cause for anxiety: an increasing
dilitation of the left ventricle and an increasing pulse
rate were ominous of commencing cardiac failure. Towards
the end of the first week it became clear that the
condition had become one of bronchopneumonia. The
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breathing was dyspnoeic, the cough hard and painful and
the sputum streaked with blood. The temperature rose
to 1020 with irregular remissions. I administered ten
grains of quinine-urea, but the oscillating nature of
the fever prevented a determination of its effect on the
temperature, and there'was no apparent improvement in
the general condition. The patient gradually sank,
became very difficult to feed and passed by slow degrees
into the typhoid state. She died on the seventeenth day
of the illness. A post mortem examination was not
made, but I am of opinion that during the last stage of
the illness the pathological condition in the lung was
largely a hypostatic pneumonia, while the broncho¬
pneumonia was in reality a secondary condition through¬
out. In all I administered four injections of quinine
urea, one of ten grains, two of fifteen grains and one
of twenty grains , when I discontinued the treatment
as it had no apj^arent effect on the course of the
disease.
CASE 6.
J.M., a woman, aged 62. This case was one.of
Dr. Syer White's patients, and I am indebted to him for
permission to record it here. I was asked to "see the
case on the ninth day of the illness. The case was
described as one of left-sided basal pneumonia which had
run the usual course up to the fifth day of the disease,
when there occurred what appeared to be a pseudo-crisis:
the temperature dropped without, a corresponding fall in
the pulse and respiration rate. The two succeeding days
were characterised by an increasing pulse and respiration
rate and a falling temperature. The following day, the
eighth of the disease, the patient collapsed; the
temperature fell to 97.8°, the pulse became extremely
rapid and there was marked cyanosis. The condition
continued critical. On the morning of the ninth day
the temperature was 97.2°, the pulse 125 and the respir¬
ations 4-8. There had been incontinence of urine during
the night, she was apathetic and there was profound
muscular prostration. The left lower lobe was consoli¬
dated and there were signs of commencing consolidation
on the right side. In view of the subnormal temperature
it was not clear what effect an injection of quinine
urea might have , but as her condition could not well
be more critical we administered eight grains intra¬
muscularly. The temperature rose within half an
hour almost two degrees - from 97,2° to 99° - while the
pulse rate fell to 100 and the respirations to 4-0.
The improvement was not maintained, and the following
day,, at 6 p.m. the temperature had fallen to 970, when
a second injection of fifteen grains of auinine urea
was succeeded by a more gradual rise in temperature
and an improvement in the general condition which held
throughout the night and well into the next day.
During the afternoon unfavourable symptoms were again
manifest and she received a third injection. In all
four injections of quinine urea were administered,
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followed in each case by a rise in temperature of a degree
or more and a corresponding improvement in the pulse
and respiration rate. The outstanding clinical feature
of the illness was the marked asthenia. It seemed as
if the pathological process in the lungs remained
stationary, while the patient gradually sank under the
weight of accumulating toxins which she was unable to
react to except under the influence of quinine urea. •
convalescence was prolonged.
CASE 7.
R.G-. , a boy, aged 19, was admitted to hospital
suffering from a severe pneumonia of the influensal type. ,
He was a groom and had been at work that morning. The
rapidity with which toxic symptoms had appeared and
his apparent collapse were evidence of the virulence
of the infection. His temperature was 104.2° , his
pulse 104- and his respirations 34. Fine indux crepitus
was audible at both bases. There was cyanosis, dyspnoea
and dilitation of the right heart associated with
mitral incompetence - that the incompetence was. due to
disease of the valve and not to relative insufficienty
was indicated at a subsequent examination. I
administered intramuscularly one c.c. of camphor in oil
followed by five grains of quinine urea. The temperature
fell to 101°, the pulse rate cane down to 92, and the
symptoms of cardiac distress were relieved. During the
second and third days of the illness thare was a
progressive weakening of the patient and an increasing
toxaemia associated ■with cardiac distress On the fourth
day a severe epistaxis relieved the heart and a second
injection of five grains of quinine urea ~ ras followed
by a fall in temperature without any appreciable
improvement in the patients condition. He now became
rapidly worse. On the fifth day the temperature rose
steadily, unchecked by a third dose of five grains
of quinine urea, and when three hours later it had
risen to 104° I administered a fourth injection of
thirteen grains.of the drug. The temperature fell to
100° and coincident with the marked slowing and steady¬
ing of the heart's 1 action there was a most gratifying
improvement in the patients general condition. The
termination was by lysis on the seventh day.
DISCUSSION.
The cases described illustrate in a more or
less marked degree the salient features of quinine
therapy. The coincident fall in temperature and relief
of toxic symptoms, exphasized by Soils Cohen, is clearly
demonstrated; while the improvement in pulse and respir¬
ation rate, though evident is generally less well marked.
It will be observed that I have not employed the massive
dosage, on which Solis Cohen lays so much stress; my
reason for this is twofold, I wished to study the effect
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of smaller doses and to control the case with the minimal
effective dose. In one case only were the smaller doses
inadequate; in this case, no 7, the first three injec¬
tions of five grains each were obviously too small and
it was not until a larger dose was employed that the
desired effect was obtained. Case Ho.6 is very interest¬
ing. It.illustrates the absence of any element of shock
following the injections and suggests that the action of
quinine urea in pneumonia is not necessarily followed by
a fall in temperature but rather by a tendency to maintain
the temperature at a level most suitable to the immediate
needs of the organism. Case No. 5. illustrates the limit
of usefulness of this drug; there was no improvement
following the injections; primarily it was not a case of
toxaemia but one of exhausted vitality, with a gradually
weakening heart and hypostatic pneumonia.
A consideration of these cases and of the
observations of Kolnier, Solis Cohen and others leaves
little room for doubt that the administration of quinine
derivatives to a pneumonia patient does profoundly
modify the course of the disease. The nature of the
action is obscure. Investigations for Its elucidation
have proceeded along two independent lines. On the
one side the interesting possibilities opened up by
Morgenroth's discovery - that ethylhydrocuprein hydro¬
chloride renders the blood of mice pneumococcicidal and
protects them against a lethal dose of pneumococcus -
led Inevitably to its clinical exhibition in pneumonia;
while on the other side Solis Cohen's experience of the
clinical value of quinine urea in pneumonia led to
experimental investigation of its action. The field of
Solis Cohen's investigations broadened and came to
include much ground that had already been covered by
those experimenting with ethylhydrocuprein hydrochloride
alone. Sir Almroth Wright, Moore, Chesney and others
all experienced disappointing results when they came to
administer ethylhydrocuprein hydrochloride to pneumonia
patients. Sir Almroth Wright considered that the failure
might be explained as a result of depression of the
phagocytic activity of the leucocytes, or because the
drug failed to penetrate the diseased lung in sufficient
quantity. Moore and Chesney attributed the failure of
the drug to the fact that it was too toxic to be given
in quantity large enough to exert any considerable
bactericidal action in the alveolar exudate. These
views, while offering an explanation of the failure of
ethylhydrocuprein hydrochloride in pneumonia, would
suggest, on the analogy of Morgenroth's experiments and
possibly'also on that of the generally accepted action
of quinine on the malarial parasite, that any benefit
which might derive from the drug should be assigned to
its bactericidal power. But a clinical investigation
into the action of other quinine derivatives - especially
quinine urea - had given results which could hardly be
ascribed to bactericidal action. If the action were a
bactericidal one relief of toxic symptoms would follow
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destruction of pneumococci in the consolidated lung area,
which, if it were possible, would no doubt be a slow-
process not in accord with the rapid improvement so
frequently experienced. But indeed the failure of
ethylhydrocuprein hydrochloride, the most powerful as a
pneunococcicidc , together with the fact that an adequate
dose of quinine urea is far too small to have any
pneumococcicidal power efectually disposes of the
bactericidal theory.
The clinical experience and preliminary labora¬
tory investigations reported by Soils Cohen and Kolmer
appeared to indicate a neutralizing action by the
quinine salt on the pneumonia poison-complex.
Experiments undertaken in.the hope of demonstrating such
action were inconclusive and. led them to suggest that the
value of quinine in pneumonia might lie in its influence
on general metabolism and on antibody production. A
review of these experiments, refered to on page 12 and
following pages , suggests that, as they are so largely
negative and in some respects contradictory, they present
no weight of evidence against the assumption that the
value of quinine urea in pneumonia is of an antitoxic
nature. There is,for example, no evidence that the
soluble endotoxin with which the experiments were conduc¬
ted and. which was first described by Cole (19) is the
poison responsible for toxic tymptoms in a pneumonia
patient. In this connection it is interesting to note
that the serum of a pneumonia patient is not more toxic
to an animal than the serum of a normal man. But to
produce the symptoms associated with a pneumonia there
must be present in the blood of the patient a. toxin:
pending the determination of this toxin, and the invest¬
igation of the action of quinine urea on it under
conditions in all respects similar to those which obtain-
in the body it is not possible to draw positive
conclusions from negative observations. That quinine
hydrobromide has power to neutralize the poisonous
property of pneumonic lung exudate is a fact of more
potential significance than the negative results of all
the other experiments. But "here again its significance
is limited by want of evidence as to whether its action
is primarily on the toxin or the tissues; while, as in
the case of the endotoxin, there is no evidence that the
toxic lung extract , which Solis Cohen prepared with great
care to avoid bacterial contamination,is responsible for
any of the symptoms in a pneumonia. The toxic property
of pneumonic lung exudate is removed by filtering through
a Berkfeld filter. Dr. Cordon55 ground up lungs showing
grey hepatisation and filtered the exudate through a
Berkfeld filter to remove bacteria, and he found that the
fi7tha.tre possessed no toxic action when injected into
rabbits.
An initial difficulty is presented to the
consideration of the subject by absence of information
as to the cause of death in many cases of pneumonia.
Excluding secondary causes of death, such as endocarditis
ox^ otitis-media, the clinical picture may be one of such
^Personally communicated: Dr. Gordon has kindly consented
to my quoting his observation;
profound toxaemia as to be incompatible with life,
or the patient may die with all the symptoms of- shook,
or again there may be no apparent reason for the sudden
death of a robust patient with one lobe only conslidated.
In the latter type of case, in an extended series of
postmortem examinations for the purpose of making
blood cultures Dr. Gordons has informed me that he
has almost invariably found that the blood in the
right auimcle was clotted and slightly adherent to
the wall. The clot was unorganized, but that is not
evidence that it was a postmortem clot. It may well
be that its sudden formation in the heart was the cause
of death, when there would not be time for it to
become organized. If this inference, deduced from
Dr. Gordon's observations, is allowed as a possibility
it will become apparent that quinine urea might prove
a valuable safeguard in this type of case apart
altogether from its more general action. It is a
common observation that it is often difficult to
obtain blood for the purpose of examination from a
pneumonia patient when that patient is in extremis.
Gulland and Goodall (20) have explained this by
demonstrating the greatly increased coagulability of
the blood in pneumonia. This increased coagulability
of the blood lends significance to the inference drawn
from Dr. Gordon's postmortem observations.
s Personally communicated: Dr. Gordon kindly consents to
my recording this observation.
34.
Cannon (21), Dale (22) and others have shown,
that whore a patient is suffering from shock, from
whatever cause produced, there is a constant indication
of the degree of shock in the hemoglobin content of
the capillary circulation. In cases of pneumonia
approaching a fatal termination the hemoglobin content
of the capillary circulation increase steadily and
may reach 112^ or more. These two factors alone - the
increased coagulability of the blood and the alteration
of the hemoglobin content - indicate a profound
modification of the blood composition which must directly
or indirectly effect an alteration in the blood
functions; and it is open to investigation whether
quinine, which is capable of .limiting acid formation
in the blood, can also modify these factors in any
way. If its administration results in a restoration
of a more normal condition of the blood there should
be diminished ri-sk of the possibility 6f sudden death
from a blood clot in the heart; while evidence
that quinine urea, when administered to a pneumonia
patient , does alter the blood composition in the manner
suggested would provide at least a partial explanation
of its value as a therapeutic agent.
The protective response in the case of lobar
pneumonia is characterised not only by the formation
of protective substances (Doches (23).) in the blood
serum, but by the deposition of fibrin in large
quantity. What purpose the fibrin serves is not
clear but it may represent an effort on the part of
the organism to localize as far as possible the
invading bacteria. That the barrier which it forms is
an insufficient obstacle is shown by the frequency
with which the pneumococcus can be isolated from the
blood; and its formation in such quantity provides
yet another example of the extravagance with which
nature's protective responses are characterised. The
deposed fibrin is a foreign protein and as such
provides a possible source of a poisonous principle
which Vaughan (24) has demonstrated in all protein
material and which is liberated when the protein
material is split up. It is possible that the toxic
symptoms in a pneumonia are to some extent in the
nature of an anaphylactic reaction to such poisonoizs
principle and that quinine urea, may limit the formation
of 'this toxin.
In septicemia peptone, when given intravenously
is followed by rigors and certain characteristic changes
in the blood. The immediate effect of peptone is to
cause the leucocytes to disappear from the blood, and
they presumably collect in the lungs. It is just like
a sudden and unexpected advance of the enemy and the
leucocyte army retreats before the advancing enemy -
the toxic peptone - for strategic reasons. Having
collected their forces at the base, and when fully
armed, the leucocytes proceed out to meet the enemy and
overwhelm them. Does quinine urea exert a similar
action in pneumonia; especially as we know that the
action of peptone is non-specific?
Yet another field for investigation is
suggested "by the observations of Dr. Gordon (25)
and others on the meningococcus which resembles the
pneumococcus in some respects. They found that the
correct antiendotoxin is only produced in horse serum
when certain definite conditions obtain. It is not
sufficient to inoculate the horse with.a graduated
series of tolerated doses of meningococci, as in the
preparation of diphtheria antitoxin, such a course
results in the production of a serum containing no
a-nin-
antiendotoxin. A serum containing the correct endo-°
A
toxin is prepared with difficulty and only when the
immunizing injections are minute and even then the
presence of the antiendotoxin in the horse serum is
a fleeting phenomenon indicating the delicate nature
of the protective mechanism and its extreme liability
to derangement. The influence of antimeningococcal
serum, containing the correct antiendotoxin, on the
mortality in meningococcal meningitis has been clearly
demonstrated. It is possible that the body is capable
of making antiendotoxin for the pneumococcus under
favourable conditions and that in this action it may be
assisted by quinine urea.
There are other problems of interest, such as
the action of quinine urea on the hemolytic activity of
the urine of pneumonia patients, elucidation of which
might help to determine the mode of action of this drug.
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,It has been suggested by Lord (26) that the
crisis and resolution of the pneumonic process is
dependent on a local biochemical Change in the course
of which the acid death point of the pneumococcus is
reached. In the absence of definite information as
to the nature of the toxaemia the problem seems well
nigh insoluble; where the factor concerned may be a
soluble toxin absorbed from living or lysed pneumo-
cocci in the consolidated area, or a toxin liberated
from deposited fibrin, or a combination of these two
or where the factor may be represented as a ans—a
faulty or incomplete response on the part of the tissues,
the problem is not likely to be approached from the
experimental stand point with much prospect of success.
While from the clinical point of view much remains to be
done. It is interesting to note that in attempting
to explore a way out through the entanglements that
beset this problem we come back to the shrewed observa¬
tions made by Schultz nearly fifty years ago and based
on clinical experience. It must be remembered that,
so far as we know, the body is the only laboratory,
capable of producing nontoxic antibodies; and it would
seem most reasonable to look for an explanation of the
value of quinine urea in pneumonia to its power to so
modify the conditions under which the tissues elaborate
their antibodies that nature is able to produce and apply
them to the best advantage.
SUMMARY AND CONCLUSIONS .
The above discussion clearly demonstrates that
in quinine urea we have a most valuable drug for the
treatment of pneumonia. It is applicable to all
clinical types of infective pneumonias and should be
regarded as an adjunct in treatment. The use of serum,
especially Type I serum in Type I cases, is of course
a well recognised form of treatment. The use of quinine
urea is of far wider application since it can be used
in any type of pneumonia, and does not suffer from the
disadvantages connected with serum treatment, e.g.
anaphylaxis, serum sickness, &c. It can be given either
in the form of massive doses or in the form of small
repeated doses. The interesting fact that patients
suffering from pneumonia do not experience any ill
effects from the quinine deserves emphasis here. It
has been shown that such patients tolerate quinine
very well even in large doses and this is true even
of persons known to be intolerant to quinine at other.
times. The drug may be given by mOuth, intravenously,
or intramuscularly but not by subcutaneous injection.
Where it is necessary to obtain rapid results or
where small doses are desired the intravenous mode
of administration is advocated. The intramuscular
method is just as efficacious in most cases and is
the method v/hich I have- latterly -adopted.
Judging by the records of the cases described
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in this paper this drug exerts a definite action on the
temperature, and in many respects resembles the effect
of Type I serum on Type I pneumococcal infections of
the lungs. The improvement in the. general condition
of the patient is however so marked a feature as to
warrant an extended use of the drug if only for this
effect alone. This immediate effect of the drug is
one which requires further explanation since there is
no doubt that by pursuing this line of investigation a
possible explanation of the exact mode of action may
be forthcoming. That the drug does not exert a
direct lethal action on the pneumococcus seems to be
proven by the work of Solis Cohen, and also by the
fact that the doses used in treatment are far too
small to have any bactericidal action. The alternative
mode of action of this drug would appear to be one of
direct action on the tissues.of the body in general.
In this respect quinine urea may produce its action in
a variety of ways. It may stimulate the formation by
the body cells of anti-endotoxin, and such an action
would be followed by an immediate improvement as occurs
in meningococcal infection. (Vide G-ordon. )
Quinine urea may exert a direct action on the
coagulability of the blood, or upon the formation of
fibrin or neutralize soluble toxins circulating in the
blood. Again we may have a series of changes produced
similar to those found after intravenous protein therapy
with the production of protein shock. If as seems likely
the intoduction of peptone intravenously causes a
rapid migration of nearly all the leucocytes into
the lungs, may not quinine urea do the same?
The above are merely tentative suggestions,
and simply serve to emphasize the fact that we know
very little as to the mode of action of this drug,
although the results of treatment are of such a
satisfactory nature that an extended application of
this drug seems amply justified.
The object of future work on this subject
is to apply the drug to a large number of cases, and
at the same time attempt to determine its plmrmacological
action. The investigation may be so arranged that
data as regards blood Changes, isolation and identifi¬
cation of endotoxin will be collected. The present
paper represents an attempt to place on record my own
experience with the use of this drug, to summarise the
present state of our knowledge, and to make suggestions
as to the lines of attack of this interestin ' and
fruitful problem.
CONCLUSIONS.
1. That quinine urea is a valuable drug in the
treatment of lobar and lobular pneumonia.
2. It acts by reducing the temperature and its
use is followed by an immediate improvement in
the general condition of the patient.
The exact nature of the action of quinine
urea in pneumonia is not understood. All
evidence is against it exerting a direct
bactericidal action on the pneumococcus.
The possibility of a direct action of
this drug on the tissues of the body appears
probable, and would explain many of the
clinical features observed.
The application of this drug to a large
number of cases of pneumonia, is contemplated
and the application of clinical pathological
methods to these cases to determine if possibl
the true pharmacological action of this drug,
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